{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:01:12Z","timestamp":1792098072475,"version":"4.4.0"},"reference-count":63,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T00:00:00Z","timestamp":1134086400000},"content-version":"vor","delay-in-days":4301,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1994,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Methotrexate (MTX) has become an important drug in the treatment of rheumatoid arthritis (RA). The American College of Rheumatology convened a committee to assess the risks of development of clinically significant liver disease (CSLD) during MTX treatment, to evaluate the risk and role of surveillance liver biopsies, and to provide recommendations about monitoring patients for liver toxicity. The committee recommends obtaining liver blood tests (alanine aminotransferase [ALT], aspartate aminotransferase [AST], alkaline phosphatase, albumin, bilirubin), hepatitis B and C serologic studies, and other standard tests including complete blood cell count and serum creatinine tests prior to starting treatment with MTX. A pretreatment liver biopsy should be considered only for patients with a history of prior excessive alcohol consumption, persistently abnormal baseline AST values, or chronic hepatitis B or C infection. At intervals of every 4\u20138 weeks the AST, ALT, and albumin levels should be monitored. Routine surveillance liver biopsies are not recommended for RA patients receiving traditional doses of MTX. However, a biopsy should be performed if a patient develops persistent abnormalities on liver blood tests. These are defined as elevations (above the upper limit of laboratory normal) in the AST in 5 of 9 determinations within a given 12\u2010month interval (6 of 12 if tests are performed monthly) or a decrease in serum albumin below the normal range. The recommendations for monitoring and selection of patients for liver biopsy identify patients at potential risk for CSLD, and thus significantly reduce the number of patients who would be exposed to this procedure. Close monitoring is essential to reduce the risk of unrecognized serious liver disease. These recommendations should be revised as necessary to reflect new and compelling information.<\/jats:p>","DOI":"10.1002\/art.1780370304","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T01:15:56Z","timestamp":1171502156000},"page":"316-328","source":"Crossref","is-referenced-by-count":464,"title":["Methotrexate for Rheumatoid Arthritis"],"prefix":"10.1002","volume":"37","author":[{"given":"Joel M.","family":"Kremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela S.","family":"Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert W.","family":"Lightfoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Willkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Furst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. James","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Dent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Weinblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,12,9]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"114","article-title":"Methotrexate in rheumatoid arthritis (abstract)","volume":"15","author":"Hoffmeister RT","year":"1972","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90477-1"},{"key":"e_1_2_1_4_2","first-page":"314","article-title":"Methotrexate: a perspective of its use in the treatment of rheumatic diseases","volume":"100","author":"Willkens RF","year":"1982","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_5_2","first-page":"860","article-title":"Low dose methotrexate in rheumatoid arthritis","volume":"9","author":"Steinsson K","year":"1982","journal-title":"J Rheumatol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198503283121303"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780280702"},{"key":"e_1_2_1_8_2","first-page":"760","article-title":"A controlled two\u2010centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis","volume":"11","author":"Thompson RN","year":"1984","journal-title":"J Rheumatol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-489"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780300401"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/29.2.120"},{"key":"e_1_2_1_12_2","first-page":"302","article-title":"Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis: a randomized, double blind 26\u2010week trial","volume":"16","author":"Morassut P","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_1_13_2","first-page":"753","article-title":"A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis","volume":"15","author":"Suarez\u2010Almazor ME","year":"1988","journal-title":"J Rheumatol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330305"},{"key":"e_1_2_1_15_2","first-page":"328","article-title":"A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis","volume":"18","author":"Rau R","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340805"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290702"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310501"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350203"},{"key":"e_1_2_1_20_2","first-page":"334","article-title":"Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study","volume":"18","author":"Weinblatt ME","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/28.2.147"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310203"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350202"},{"key":"e_1_2_1_24_2","first-page":"994","article-title":"Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14\u2010year prospective evaluation of 1017 consecutive starts","volume":"17","author":"Wolfe F","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320603"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(82)80064-9"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)80237-8"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-418"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310301"},{"key":"e_1_2_1_30_2","first-page":"1180","article-title":"Methotrexateinduced liver abnormalities in rheumatoid arthritis","volume":"16","author":"Bridges SL","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_1_31_2","first-page":"189","article-title":"Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going","volume":"19","author":"Kremer JM","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_1_32_2","first-page":"1628","article-title":"Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis","volume":"17","author":"Furst DE","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_1_33_2","first-page":"313","article-title":"Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis","volume":"16","author":"Furst DE","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_1_34_2","volume-title":"Beyond Normality: The Predictive Value and Efficiency of Medical Diagnoses","author":"Galen RS","year":"1975"},{"issue":"4","key":"e_1_2_1_35_2","first-page":"S18","article-title":"Pretreatment liver histology in rheumatoid arthritis patients treated with low dose methotrexate (abstract)","volume":"29","author":"Tolman KG","year":"1986","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320202"},{"issue":"4","key":"e_1_2_1_37_2","first-page":"S17","article-title":"Baseline and follow\u2010up liver histology in rheumatoid arthritis patients receiving pulse methotrexate (abstract)","volume":"30","author":"Kremer JM","year":"1987","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_38_2","first-page":"503","article-title":"Low\u2010dose weekly oral methotrexate therapy for inflammatory arthritis","volume":"5","author":"Boh LE","year":"1986","journal-title":"Clin Pharm"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(89)90085-1"},{"key":"e_1_2_1_40_2","first-page":"489","article-title":"Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate","volume":"16","author":"Rau R","year":"1989","journal-title":"J Rheumatol"},{"issue":"4","key":"e_1_2_1_41_2","first-page":"S14","article-title":"Liver histology in rheumatoid arthritis before and after prolonged methotrexate therapy (abstract)","volume":"28","author":"Koo AP","year":"1985","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_42_2","first-page":"229","article-title":"Clinical liver disease in patients with rheumatoid arthritis taking methotrexate","volume":"19","author":"Phillips CA","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212313272702"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.8.848"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90312-2"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.8.591"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(88)80019-6"},{"issue":"9","key":"e_1_2_1_48_2","first-page":"S40","article-title":"Long\u2010term prospective sequential liver biopsies in patients with rheumatoid arthritis on weekly oral methotrexate (abstract)","volume":"33","author":"Kremer JM","year":"1990","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780311201"},{"key":"e_1_2_1_50_2","first-page":"29","article-title":"Methotrexate and the liver","volume":"12","author":"Tolman KG","year":"1985","journal-title":"J Rheumatol"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009748709102922"},{"issue":"9","key":"e_1_2_1_52_2","first-page":"S161","article-title":"Serial liver biopsies from methotrexate\u2010treated rheumatoid arthritis patients (abstract)","volume":"34","author":"Sawitzke AD","year":"1991","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780321004"},{"key":"e_1_2_1_54_2","first-page":"1123","article-title":"Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis","volume":"16","author":"Clegg DO","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330717"},{"issue":"9","key":"e_1_2_1_56_2","first-page":"S60","article-title":"Prospective study of hepatotoxicity in patients receiving methotrexate for rheumatoid arthritis (abstract)","volume":"33","author":"Augur NA","year":"1990","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360307"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(05)80060-9"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1973.01620220008002"},{"key":"e_1_2_1_60_2","first-page":"511","article-title":"Liver biopsies from psoriatics related to methotrexate therapy: 3. Findings in post\u2010methotrexate liver biopsies from 160 psoriatics","volume":"85","author":"Nyfors A","year":"1977","journal-title":"Acta Pathol Microbiol Scand [A]"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1980.tb06553.x"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-2-199301150-00013"},{"issue":"5","key":"e_1_2_1_63_2","first-page":"R32","article-title":"The cost\u2010effectiveness of liver biopsy in rheumatoid arthritis patients on methotrexate (abstract)","volume":"36","author":"Bergquist SR","year":"1993","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(86)80075-7"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780370304","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780370304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:36:45Z","timestamp":1700699805000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780370304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["10.1002\/art.1780370304"],"URL":"https:\/\/doi.org\/10.1002\/art.1780370304","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}